All Posts:nonalcoholic fatty liver disease

• New Drug Prevents Liver Damage, Obesity and Glucose Intolerance in Mice on High-Fat Diet

  WASHINGTON (January 21, 2020) — Mice given a new drug targeting a key gene involved in lipid and glucose metabolism could tolerate a high-fat diet regimen (composed of 60% fat from lard) without developing significant liver damage, becoming obese, or disrupting their body’s glucose balance. The study by Georgetown Lombardi Comprehensive Cancer Center researchers appeared […]

  Category: News Release Tags: cancer, cancer research, liver cancer, nonalcoholic fatty liver disease